MENU
+Compare
VTGN
Stock ticker: NASDAQ
AS OF
Jul 18 closing price
Price
$2.55
Change
+$0.01 (+0.39%)
Capitalization
74.35M

VTGN VistaGen Therapeutics Forecast, Technical & Fundamental Analysis

Vistagen Therapeutics Inc is a biotechnology firm... Show more

Industry: #Biotechnology
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VTGN with price predictions
Jul 18, 2025

VTGN's RSI Oscillator ascends from oversold territory

The RSI Oscillator for VTGN moved out of oversold territory on June 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 07, 2025. You may want to consider a long position or call options on VTGN as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VTGN just turned positive on July 07, 2025. Looking at past instances where VTGN's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

VTGN moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VTGN crossed bullishly above the 50-day moving average on July 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTGN advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VTGN broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VTGN entered a downward trend on July 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VTGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.056) is normal, around the industry mean (18.109). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). VTGN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (161.290) is also within normal values, averaging (270.773).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VTGN is expected to report earnings to fall 88.64% to -5 cents per share on June 27

VistaGen Therapeutics VTGN Stock Earnings Reports
Q1'23
Est.
$-0.05
Q1'25
Beat
by $0.41
Q2'23
Beat
by $1.31
Q4'22
Beat
by $0.02
Q3'22
Missed
by $0.01
The last earnings report on June 17 showed earnings per share of -43 cents, beating the estimate of -85 cents. With 276.20K shares outstanding, the current market capitalization sits at 74.35M.
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMCHY1.53N/A
N/A
DMCI Holdings Inc.
SPXSF83.12N/A
N/A
SPIRAX GROUP PLC
FGPRB131.00N/A
N/A
Ferrellgas Partners, L.P.
DBOXF0.22-0.01
-6.37%
D-Box Technologies, Inc.
SDRC0.30-0.02
-7.31%
Sidney Resources Corp.

VTGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+0.39%
ABOS - VTGN
44%
Loosely correlated
+1.35%
COGT - VTGN
42%
Loosely correlated
+2.38%
IMNM - VTGN
42%
Loosely correlated
+1.24%
IPSC - VTGN
41%
Loosely correlated
+0.10%
ALEC - VTGN
40%
Loosely correlated
-4.79%
More